Phase II Study of Ridaforolimus (MK-8669) With Metastatic Bone or Soft-tissue Sarcoma Patients (MK-8669-030 AM1)
Clinical trial NCT01010672 · COMPLETED
Trial details
- NCT number
- NCT01010672
- Sponsor
- Merck Sharp & Dohme LLC
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2009-11-01
- Primary completion
- 2011-09-01
- Enrollment
- 50
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.